Polyphor's IPO

Polyphor raised a round of funding on May 15, 2018. Investors include Public.

Polyphor is a clinical-stage Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases. The company's lead drug candidates…

Articles about Polyphor's IPO: